Market Value6,405,753,000
Total Holdings111
File Date2021-05-14
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
ASLN / ASLAN Pharmaceuticals Limited - Depositary Receipt (Common Stock)
HLXA / Helix Acquisition Corp - Class A
APYX / Apyx Medical Corporation
ATHA / Athira Pharma, Inc.
BLSA / BCLS Acquisition Corp - Class A
NAUT / Nautilus Biotechnology, Inc.
KURA / Kura Oncology, Inc.
US33830X1046 / Five Prime Therapeutics Inc
PHGE.WS / BiomX Inc. Warrants to purchase one-half of a share of
US3723091043 / GenMark Diagnostics, Inc
KYG5960S1167 / Medicus Sciences Acquisition Corp. Unit
CERN / Cerner Corp.
NUVB.WS / Panacea Acquisition Corp. - Equity Warrant
TBIO / Telesis Bio, Inc.
CRIS / Curis, Inc.
MASS / 908 Devices Inc.
RACB / Research Alliance Corp II - Class A
FVAM / 5:01 Acquisition Corp.
DMTK / DermTech, Inc.
LJPC / La Jolla Pharmaceutical Co.
PEN / Penumbra, Inc.
BCAB / BioAtla, Inc.
TNDM / Tandem Diabetes Care, Inc.
VINC / Vincerx Pharma, Inc.
CHAQ.U / Chardan Healthcare Acquisition 2 Corp. Units, each consisting of one share of , and one
US92731L1145 / Vincerx Pharma, Inc.
LUNG / Pulmonx Corporation
NUVB / Nuvation Bio Inc.
AZYO / Aziyo Biologics Inc - Class A
INMD / InMode Ltd.
PROF / Profound Medical Corp.
SEER / Seer, Inc.
/ Cerevel Therapeutics Holdings, Inc. Warrant
PAYX / Paychex, Inc.
FULC / Fulcrum Therapeutics, Inc.
PRQR / ProQR Therapeutics N.V.
TNGX / Tango Therapeutics, Inc.
PHGE / BiomX Inc.
ODT / Odonate Therapeutics Inc
NSTG / NanoString Technologies, Inc.
EPIX / ESSA Pharma Inc.
BLI / Berkeley Lights Inc
LSAQ / LifeSci Acquisition II Corp
IMUX / Immunic, Inc.
SRRK / Scholar Rock Holding Corporation
CNTB / Connect Biopharma Holdings Limited - Depositary Receipt (Common Stock)
BOLT / Bolt Biotherapeutics, Inc.
ADVM / Adverum Biotechnologies, Inc.
ARGX / argenx SE - Depositary Receipt (Common Stock)
ITOS / iTeos Therapeutics, Inc.
BDSX / Biodesix, Inc.
DRNA / Dicerna Pharmaceuticals Inc
AFIB / Acutus Medical, Inc.
CERE / Cerevel Therapeutics Holdings, Inc.
TARS / Tarsus Pharmaceuticals, Inc.
CLSD / Clearside Biomedical, Inc.
QDEL / QuidelOrtho Corporation
/ Conyers Park Acquisition Corp.
JNJ / Johnson & Johnson
GTH / Genetron Holdings Limited - Depositary Receipt (Common Stock)
PSNL / Personalis, Inc.
OM / Outset Medical, Inc.
SPY / SPDR S&P 500 ETF
IDYA / IDEAYA Biosciences, Inc.
MDXG / MiMedx Group, Inc.
RCEL / AVITA Medical, Inc.
OYST / Oyster Point Pharma Inc
FREQ / Frequency Therapeutics Inc
TELA / TELA Bio, Inc.
OSUR / OraSure Technologies, Inc.
BIOR / Biora Therapeutics, Inc.
BNR / Burning Rock Biotech Limited - Depositary Receipt (Common Stock)
OLK / Olink Holding AB (publ) - Depositary Receipt (Common Stock)
ABUS / Arbutus Biopharma Corporation
VCEL / Vericel Corporation
AVDL / Avadel Pharmaceuticals plc
BLU / Bellus Health Inc
TWST / Twist Bioscience Corporation
TRIL / Trillium Therapeutics Inc
MRVI / Maravai LifeSciences Holdings, Inc.
BWAY / BrainsWay Ltd. - Depositary Receipt (Common Stock)
IMVT / Immunovant, Inc.
CHAQ / Chardan Healthcare Acquisition 2 Corp
CCCC / C4 Therapeutics, Inc.
MGNX / MacroGenics, Inc.
AXNX / Axonics, Inc.
ISEE / IVERIC bio Inc
TXG / 10x Genomics, Inc.
ARYD / ARYA Sciences Acquisition Corp IV
MRTX / Mirati Therapeutics, Inc.
APVO / Aptevo Therapeutics Inc.
LABP / Landos Biopharma, Inc.
RXDX / Prometheus Biosciences Inc
PMVP / PMV Pharmaceuticals, Inc.
CSTL / Castle Biosciences, Inc.
CYTK / Cytokinetics, Incorporated
XGN / Exagen Inc.
AGEN / Agenus Inc.
RGNX / REGENXBIO Inc.
ILMN / Illumina, Inc.
CLDX / Celldex Therapeutics, Inc.
ARVN / Arvinas, Inc.
GMED / Globus Medical, Inc.
IMCR / Immunocore Holdings plc - Depositary Receipt (Common Stock)
CTMX / CytomX Therapeutics, Inc.
ESTA / Establishment Labs Holdings Inc.
STOK / Stoke Therapeutics, Inc.
RNA / Avidity Biosciences, Inc.
GH / Guardant Health, Inc.
MASI / Masimo Corporation
AXSM / Axsome Therapeutics, Inc.
ALNY / Alnylam Pharmaceuticals, Inc.
RLMD / Relmada Therapeutics, Inc.
PTCT / PTC Therapeutics, Inc.
PTGX / Protagonist Therapeutics, Inc.
MIST / Milestone Pharmaceuticals Inc.
NTRA / Natera, Inc.
RCKT / Rocket Pharmaceuticals, Inc.
IMTX / Immatics N.V.